Diagnostic value of screening tests in subgroups of women with recurrent pregnancy loss

Basit Öğe Kaydı
dc.contributor.authorGuzel, Ali Irfan
dc.contributor.authorErkilinc, Selcuk
dc.contributor.authorOzer, Irfan
dc.contributor.authorCelik, Yusuf
dc.contributor.authorYilmaz, Nafiye
dc.contributor.authorDoganay, Melike
dc.date.accessioned2024-04-24T17:20:33Z
dc.date.available2024-04-24T17:20:33Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: To evaluate the diagnostic value of screening laboratory tests in women who had recurrent pregnancy loss (RPL). Methods: A total of 252 women with RPL managed in our tertiary referral research and education hospital were included in the study. Risk factors recorded involved age, gravidity, parity, number of prior live births, number of pregnancy losses, and thrombophlia tests. The cases were divided into three different groups and each group was analyzed separately. Results: There was no statistically significant difference between the first and second groups in terms of clinical and laboratory parameters (p>0.05). In the third group, there was a statistically significant difference among cases in terms of parity, gravidity, number of pregnancy losses, serum AT III levels, APCR, and age of the women. According to the logistic regression model, odds ratios (95% CI) were 6.116 (3.797-9.852), 5.665 (2.657-12.079), 4.763 (3.099-7.321), 4.729 (3.080-7.260), 2.820 (1.836-4.333), and 1.911 (1.232-2.965), respectively. Conclusions: We do not recommend the screening of all women with RPL, but in women with high parity and those who had prior live birth pregnancies, increased AT III, and APCR may be diagnostic markers for subsequent pregnancy loss.en_US
dc.identifier.doi10.3109/14767058.2014.920811
dc.identifier.endpage447en_US
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue4en_US
dc.identifier.pmid24783967
dc.identifier.scopus2-s2.0-84924420226
dc.identifier.scopusqualityQ1
dc.identifier.startpage443en_US
dc.identifier.urihttps://doi.org/10.3109/14767058.2014.920811
dc.identifier.urihttps://hdl.handle.net/11468/19124
dc.identifier.volume28en_US
dc.identifier.wosWOS:000351133400014
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiagnostic Valueen_US
dc.subjectRecurrent Pregnancy Lossen_US
dc.subjectScreening Testsen_US
dc.subjectSubgroupen_US
dc.titleDiagnostic value of screening tests in subgroups of women with recurrent pregnancy lossen_US
dc.titleDiagnostic value of screening tests in subgroups of women with recurrent pregnancy loss
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu